ICG-NIR Guided Lymph Node Dissection in Gastric Cancer

Status Not yet recruiting

Clinical Trial Summary

As the survival rate of patients with gastric cancer has increased, there has been a growing interest in interventions that improve postoperative quality of life. Therefore minimally invasive surgery or endoscopic resection has been performed much more frequently. However, adequate lymph node dissection is important as well. The aim of the study is to identify the feasibility of indocyanine green - near infra-red (ICG-NIR) guided sentinel lymph node dissection for the treatment of gastric cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04056260
Study type	Interventional
Source	Seoul St. Mary's Hospital
Contact
Status	Not yet recruiting
Phase	N/A
Start date	March 20, 2020
Completion date	December 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03313700` - Clinical Outcomes of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer	N/A
Recruiting	`NCT05645198` - The Effect of Carboxymetyl Starch (Oozfix) on Preventing Postoperative Complication After Gastrectomy	Phase 4
Completed	`NCT03549494` - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction	Phase 2
Completed	`NCT00935779` - Ultra Structure Of Peritoneum At Electronic Microscopy In Control Subjects And Patients With Gastric Cancer	N/A
Completed	`NCT00144378` - Irinotecan Versus Only Best Supportive Care for Gastric Cancer	Phase 3
Completed	`NCT00290966` - Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer	Phase 2/Phase 3
Recruiting	`NCT03348150` - Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.	Phase 3
Not yet recruiting	`NCT06085677` - The Gastric HormonE BioMarkers of Preneoplastic Lesions Study
Recruiting	`NCT02969122` - Treatment Strategy for Stage IV Gastric Cancer With Positive Peritoneal Cytology as the Only Non-curable Factor	N/A
Completed	`NCT01482299` - RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression	Phase 2
Active, not recruiting	`NCT03760822` - Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients	Phase 2
Recruiting	`NCT00509964` - Second-Line Irinotecan vs. ILF for AGC	Phase 2
Completed	`NCT04889859` - Impact of Biliopancreatic Limb Length on Diabetes Following Distal Gastrectomy	N/A
Completed	`NCT03071237` - The Origin of Infrapyloric Artery
Recruiting	`NCT05184803` - A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer	Phase 2
Completed	`NCT05714878` - Multimodal Prehabilitation for Resectable Gastric Cancer	N/A
Completed	`NCT00142038` - Docetaxel and Capecitabine in Advanced Gastric Cancer	Phase 2
Recruiting	`NCT03065257` - Endoscopic Resection Multicenter Registry	N/A
Recruiting	`NCT04744649` - Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial	Phase 2
Recruiting	`NCT05640609` - Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer	Phase 1/Phase 2